Table 4. Cell viability and proliferative activity of chondrocytes.

Ref.	Sources	Interventions		Outcomes
		T-2 toxin	Time	Cell viability (MTT assay)	Proliferation (Cell counting)
Wang et al. 201238	Human (C28/I2)	1.5625–400 ng ml–1	2–5 d	↓
Han et al. 201339	Human	1–500 ng ml–1	2–5 d	↓
Liu et al. 201440	Human	1–100 ng ml–1	3–5 d	↓
Yang et al. 200141	Human fetus	1–8 μg l–1	3–7 d		↓
Yang et al. 200142	Human fetus	5, 10, 20, 40 μg l–1	3–7 d		↓
Chen et al. 200627	Human fetus	1, 10, 20 ng ml–1	3–5 d	↓
Chen et al. 200643	Human fetus	0.001–8 mg l–1	3–5 d	↓
Chen et al. 200628	Human fetus	1–8000 ng ml–1	2–5 d	↓
Chen et al. 200844	Human fetus	1–8000 ng ml–1	3–5 d	↓
Chen et al. 201145	Human fetus	1–8000 ng ml–1	3–5 d	↓
He et al. 201146	Broiler chicken	10, 100, 1000 nm/5, 50, 500, 5000 nmol l–1	3, 6, 9 d/48, 72 h	↓
Liu et al. 200847	Zelanian rabbit	1, 10, 20, 100 μg l–1	1–5 d	↓
Liu et al. 201148	Zelanian rabbit	1, 10, 20, 100 μg l–1	1–5 d	↓
Tian et al. 201249	Murine (ATDC5)	10, 20, 40, 80 μg l–1	6, 12, 24 h	↓